The report focuses on the Beta-lactam and Beta-lactamase Inhibitors market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Beta-lactam and Beta-lactamase Inhibitors market.
Major Players in the Beta-lactam and Beta-lactamase Inhibitors market are:
GlaxoSmithKline
Novartis International AG
Allergan
Sanofi
Abbott Laboratories
Merck & Co. lnc.
Roche Holding AG
Pfizer Inc.
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
On the basis of types, the Beta-lactam and Beta-lactamase Inhibitors market is primarily split into:
Amoxicillin
Ampicillin
Cephalexin
Penicillin
Cephalosporin
Carbapenem
Monobactam
Combination
Others
On the basis of applications, the market covers:
Oral Dosage Forms
Others
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Beta-lactam and Beta-lactamase Inhibitors Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 Beta-lactam and Beta-lactamase Inhibitors Market Overview
1.1 Product Overview and Scope of Beta-lactam and Beta-lactamase Inhibitors Market
1.2 Beta-lactam and Beta-lactamase Inhibitors Market Segment by Type
1.2.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Beta-lactam and Beta-lactamase Inhibitors Market Segment by Application
1.3.1 Beta-lactam and Beta-lactamase Inhibitors Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Beta-lactam and Beta-lactamase Inhibitors Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Beta-lactam and Beta-lactamase Inhibitors (2017-2029)
1.5.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Beta-lactam and Beta-lactamase Inhibitors Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Beta-lactam and Beta-lactamase Inhibitors Industry
1.7 Impact of Carbon Neutrality on the Beta-lactam and Beta-lactamase Inhibitors Industry
2 Beta-lactam and Beta-lactamase Inhibitors Market Upstream and Downstream Analysis
2.1 Beta-lactam and Beta-lactamase Inhibitors Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Beta-lactam and Beta-lactamase Inhibitors Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 GlaxoSmithKline
3.1.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Beta-lactam and Beta-lactamase Inhibitors Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Novartis International AG
3.2.1 Novartis International AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Beta-lactam and Beta-lactamase Inhibitors Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Allergan
3.3.1 Allergan Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Beta-lactam and Beta-lactamase Inhibitors Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Sanofi
3.4.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Beta-lactam and Beta-lactamase Inhibitors Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Abbott Laboratories
3.5.1 Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Beta-lactam and Beta-lactamase Inhibitors Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Merck & Co. lnc.
3.6.1 Merck & Co. lnc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Beta-lactam and Beta-lactamase Inhibitors Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Roche Holding AG
3.7.1 Roche Holding AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Beta-lactam and Beta-lactamase Inhibitors Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Pfizer Inc.
3.8.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Beta-lactam and Beta-lactamase Inhibitors Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Mylan N.V.
3.9.1 Mylan N.V. Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Beta-lactam and Beta-lactamase Inhibitors Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Teva Pharmaceutical Industries Ltd.
3.10.1 Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Beta-lactam and Beta-lactamase Inhibitors Market Performance (2017-2022)
3.10.4 Business Overview
4 Global Beta-lactam and Beta-lactamase Inhibitors Market Landscape by Player
4.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales and Share by Player (2017-2022)
4.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Market Share by Player (2017-2022)
4.3 Global Beta-lactam and Beta-lactamase Inhibitors Average Price by Player (2017-2022)
4.4 Global Beta-lactam and Beta-lactamase Inhibitors Gross Margin by Player (2017-2022)
4.5 Beta-lactam and Beta-lactamase Inhibitors Market Competitive Situation and Trends
4.5.1 Beta-lactam and Beta-lactamase Inhibitors Market Concentration Rate
4.5.2 Beta-lactam and Beta-lactamase Inhibitors Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue, Price Trend by Type
5.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales and Market Share by Type (2017-2022)
5.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Market Share by Type (2017-2022)
5.3 Global Beta-lactam and Beta-lactamase Inhibitors Price by Type (2017-2022)
5.4 Global Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Growth Rate of Amoxicillin (2017-2022)
5.4.2 Global Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Growth Rate of Ampicillin (2017-2022)
5.4.3 Global Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Growth Rate of Cephalexin (2017-2022)
5.4.4 Global Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Growth Rate of Penicillin (2017-2022)
5.4.5 Global Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Growth Rate of Cephalosporin (2017-2022)
5.4.6 Global Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Growth Rate of Carbapenem (2017-2022)
5.4.7 Global Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Growth Rate of Monobactam (2017-2022)
5.4.8 Global Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Growth Rate of Combination (2017-2022)
5.4.9 Global Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Growth Rate of Others (2017-2022)
6 Global Beta-lactam and Beta-lactamase Inhibitors Market Analysis by Application
6.1 Global Beta-lactam and Beta-lactamase Inhibitors Consumption and Market Share by Application (2017-2022)
6.2 Global Beta-lactam and Beta-lactamase Inhibitors Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Beta-lactam and Beta-lactamase Inhibitors Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Beta-lactam and Beta-lactamase Inhibitors Consumption and Growth Rate of Oral Dosage Forms (2017-2022)
6.3.2 Global Beta-lactam and Beta-lactamase Inhibitors Consumption and Growth Rate of Others (2017-2022)
7 Global Beta-lactam and Beta-lactamase Inhibitors Sales and Revenue Region Wise (2017-2022)
7.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales and Market Share, Region Wise (2017-2022)
7.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Beta-lactam and Beta-lactamase Inhibitors Market Forecast (2022-2029)
8.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue Forecast (2022-2029)
8.1.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Beta-lactam and Beta-lactamase Inhibitors Price and Trend Forecast (2022-2029)
8.2 Global Beta-lactam and Beta-lactamase Inhibitors Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Beta-lactam and Beta-lactamase Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Beta-lactam and Beta-lactamase Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.3 China Beta-lactam and Beta-lactamase Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Beta-lactam and Beta-lactamase Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.5 India Beta-lactam and Beta-lactamase Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Beta-lactam and Beta-lactamase Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Beta-lactam and Beta-lactamase Inhibitors Sales and Revenue Forecast (2022-2029)
8.3 Global Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate of Amoxicillin (2022-2029)
8.3.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate of Ampicillin (2022-2029)
8.3.3 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate of Cephalexin (2022-2029)
8.3.4 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate of Penicillin (2022-2029)
8.3.5 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate of Cephalosporin (2022-2029)
8.3.6 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate of Carbapenem (2022-2029)
8.3.7 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate of Monobactam (2022-2029)
8.3.8 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate of Combination (2022-2029)
8.3.9 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate of Others (2022-2029)
8.4 Global Beta-lactam and Beta-lactamase Inhibitors Consumption Forecast by Application (2022-2029)
8.4.1 Global Beta-lactam and Beta-lactamase Inhibitors Consumption Value and Growth Rate of Oral Dosage Forms (2022-2029)
8.4.2 Global Beta-lactam and Beta-lactamase Inhibitors Consumption Value and Growth Rate of Others (2022-2029)
8.5 Beta-lactam and Beta-lactamase Inhibitors Market Forecast Under COVID-19
9 Industry Outlook
9.1 Beta-lactam and Beta-lactamase Inhibitors Market Drivers Analysis
9.2 Beta-lactam and Beta-lactamase Inhibitors Market Restraints and Challenges
9.3 Beta-lactam and Beta-lactamase Inhibitors Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Beta-lactam and Beta-lactamase Inhibitors Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Beta-lactam and Beta-lactamase Inhibitors Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Beta-lactam and Beta-lactamase Inhibitors Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global Biopharmaceuticals Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 155
According to our LPI (LP Information) latest study, the global Biopharmaceuticals market size was valued at US$ 31700 million in 2023. With growing demand in downstream market, the Biopharmaceuticals is forecast to a readjusted size of US$ 55380 million by 2030 with a CAGR of 8.3% during review period.
The research report highlights the growth potential of the global Biopharmaceuticals market. Biopharmaceuticals are expected to show stable growth in the future market. However, product di......
Global Bio-Pharma Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 118
Market Overview of Global Bio-Pharma market:
According to our latest research, the global Bio-Pharma market looks promising in the next 5 years. As of 2022, the global Bio-Pharma market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Bio-Pharma market, with a systematical de......
Global Bio-pharma Market Research Report 2023
Published: 28-Dec-2023 Price: US 2900 Onwards Pages: 91
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Bio-pharma market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Pfizer
- F. Hoffmann-La Roche AG
- Johnson & Johnson Services
- Sanofi, Amgen
- AbbVie
- Merck & Co., Inc
- Biogen Idec
- Bayer AG
- E......
Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation (Commercial, Clinical), Application (mAbs, Vaccines, Cell & Gene Therapy), & End User - Global Forecast to 2028
Published: 24-Nov-2023 Price: US 4950 Onwards Pages: 273
“Rising demand for biopharmaceuticals and growing adoption among CDMOs and CMOs are driving the growth of the continuous bioprocessing market.”
The global continuous bioprocessing market is projected to reach USD 599 million by 2028 from USD 218 million in 2023, at a CAGR of 22.4% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the increasing adoption of continuous bioprocessing among CDMOs and CMOs. Continuous b......
Global Biopharmaceuticals Professional Survey Report 2023, Forecast to 2028
Published: 20-Nov-2023 Price: US 3280 Onwards Pages: 139
A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of em......
Global Biopharmaceuticals Market Research Report 2023, Forecast to 2028
Published: 20-Nov-2023 Price: US 2680 Onwards Pages: 160
A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of em......
2023-2031 Report on Global Biopharmaceuticals Market by Player, Region, Type, Application and Sales Channel
Published: 18-Sep-2023 Price: US 2500 Onwards Pages: 85
This report studies the Biopharmaceuticals market, covering market size for segment by type (Monoclonal Antibodies, Interferon, etc.), by application (Tumor, Diabetes, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Roche, Amgen, Abbvie, Sanofi-Aventis, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Biopharmaceutic......
Global Bio-pharma Market Insights, Forecast to 2029
Published: 10-Aug-2023 Price: US 4900 Onwards Pages: 108
The global Bio-pharma market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Bio-pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Bio-pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of......
Biopharmaceuticals Markets in China
Published: 24-Jul-2023 Price: US 4000 Onwards Pages: 233
China's demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, indu......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
